Human Papillomavirus (HPV) Infections (DBCOND0147773)

Identifiers

Synonyms
Human Papillomavirus Infections / Human Papilloma Virus Infection / Human Papillomavirus Infection / Human Papillomavirus (HPV) Infection / HPV infection / Human papillomavirus infection (disorder) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Human papillomavirus type 11 L1 capsid protein antigen
Human papillomavirus type 11 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is...
No drug targets
Human papillomavirus type 16 L1 capsid protein antigen
Human papillomavirus type 16 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is...
No drug targets
Human papillomavirus type 18 L1 capsid protein antigen
Human papillomavirus type 18 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is...
No drug targets
Human papillomavirus type 31 L1 capsid protein antigen
Human papillomavirus type 31 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of...
No drug targets
Human papillomavirus type 33 L1 capsid protein antigen
Human papillomavirus type 33 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of...
No drug targets
Human papillomavirus type 45 L1 capsid protein antigen
Human papillomavirus type 45 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of...
No drug targets
Human papillomavirus type 52 L1 capsid protein antigen
Human papillomavirus type 52L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of age...
No drug targets
Human papillomavirus type 58 L1 capsid protein antigen
Human papillomavirus type 58 L1 capsid protein antigen is contained in Gardasil is a vaccine for intramuscular injection. It is an immunization for young men and women 9-26 years of...
No drug targets
Human papillomavirus type 6 L1 capsid protein antigen
Human papillomavirus type 6 L1 capsid protein antigen is contained in Gardasil, or a recombinant Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) vaccine for intramuscular injection. It is...
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02009800
ICI-VPH: Impact of HPV Immunisation Schedules Against HPVprevention3completed
NCT01717443
Genital HPV Infections Before and After Renal TransplantationNo drug interventionsNot AvailableNot Availablecompleted
NCT01077856
GARDASIL™ Vaccine Impact in Population Study (V501-033)No drug interventionsNot AvailableNot Availablecompleted
NCT03610581
Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the CervixNo drug interventionstreatment1 / 2terminated
NCT05316064
Reducing Abundance of Human Papilloma Virus in Women by Taking Probiotictreatment2 / 3withdrawn
NCT04002154
Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPVNo drug interventionstreatmentNot Availablecompleted
NCT04391647
Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine SamplesNo drug interventionsNot AvailableNot Availablecompleted
NCT01387997
e- Ab Sensor-based Real-time Detection of Oncogenic Human Papilloma VirusesNo drug interventionsdiagnosticNot Availableunknown_status
NCT05439083
Immunogenicity of 9-valent HPV VaccineNo drug interventionshealth_services_research4recruiting
NCT04199078
Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.No drug interventionstreatmentNot Availableactive_not_recruiting
NCT02258659
Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancertreatment2active_not_recruiting
NCT01901770
The Parents in Appalachia Receive Education Needed for Teen ProjectNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT01567813
Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070)No drug interventionsNot AvailableNot Availablecompleted
NCT05510830
Diagnostic Cervical Conization for Persistent Infection or Integration of HPVNo drug interventionsdiagnosticNot Availablenot_yet_recruiting
NCT01898494
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancertreatment2active_not_recruiting
NCT02811367
The HPV Self-test as a Test of Cure in MadagascarNo drug interventionsdiagnosticNot Availablecompleted
NCT04624568
Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and ToleranceNo drug interventionstreatmentNot Availablecompleted
NCT02714114
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)No drug interventionsNot AvailableNot Availablecompleted
NCT00303823
Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial NeoplasiaNo drug interventionsprevention2completed
NCT02634190
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® SpecimensNo drug interventionsNot AvailableNot Availablecompleted
NCT06123533
Understanding Women's Values in Managing Human Papillomavirus (HPV)No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01446198
Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT05694728
A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccineprevention2completed
NCT06111911
Detection of High-Risk HPV in Urine and Cervical Swab Specimen Using HPV Diagnostic Kit (Bio Farma)No drug interventionsdiagnosticNot Availablecompleted
NCT02067507
Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles CountyNo drug interventionspreventionNot Availablecompleted
NCT02124252
Community-Driven Cervical Cancer Prevention in Western KenyaNo drug interventionshealth_services_researchNot Availablecompleted
NCT06467942
Effects of Chinese Medicine and Lactobacillus in Persistent HPV InfectiontreatmentNot Availablerecruiting
NCT02135419
Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesionsprevention3completed
NCT00054041
Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasiatreatment2completed
NCT04117386
Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With PterygiumNo drug interventionsNot AvailableNot Availablecompleted
NCT01946139
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIVNo drug interventionsscreeningNot Availablecompleted
NCT02048020
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancertreatment2completed
NCT03542227
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void UrineNo drug interventionsNot AvailableNot Availablecompleted
NCT03677960
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionNo drug interventionstreatment1terminated
NCT03202992
Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionNo drug interventionstreatment1completed
NCT01539668
Hybrid Capture Test on Mobile Unit Program to Improve Cervical Cancer Screening in Brazilian Rural and Remote AreasNo drug interventionsNot AvailableNot Availablecompleted
NCT06611553
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)No drug interventionspreventionNot Availablerecruiting
NCT03180034
Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Studyprevention4enrolling_by_invitation
NCT04472377
HPV Typing Between Self- and Physician-sampledNo drug interventionsdiagnosticNot Availablecompleted
NCT06611540
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)No drug interventionspreventionNot Availablerecruiting
NCT06362421
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06491446
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal InsertsNo drug interventionstreatment1 / 2recruiting
NCT06498661
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)No drug interventionspreventionNot Availablerecruiting
NCT06598475
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a AdolescentsNo drug interventionspreventionNot Availablenot_yet_recruiting
NCT00931190
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical DysplasiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00867464
Extended Follow Up of Young Women in Costa Rica Who Received Vaccine for Human Papillomavirus Types 16 and 18 and Unvaccinated ControlsNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00551187
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)No drug interventionsprevention2completed
NCT03000933
Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)No drug interventionsNot AvailableNot Availablecompleted
NCT03309033
Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06582654
Normalizing Antibody Detection in First-void UrineNo drug interventionsNot AvailableNot Availablerecruiting
NCT06557954
Cervical Cytology DNA Methylation for Cervical Cancer ScreeningNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT03726151
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCsNo drug interventionspreventionNot Availableenrolling_by_invitation
NCT01095198
Randomized Trial of Vaginal Self Sampling for Human Papillomavirus (HPV)No drug interventionsprevention2 / 3unknown_status
NCT04142398
Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01932697
Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancertreatment2completed
NCT01550783
Home-Based or Clinic-Based Human Papillomavirus (HPV) ScreeningNo drug interventionsscreeningNot Availablecompleted
NCT01693783
Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancertreatment2completed
NCT05613283
Primary Cervical Cancer Screening by Self-sampling HPV TestNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03887793
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery SystemsNo drug interventionshealth_services_researchNot Availablewithdrawn
NCT03961178
A Cohort Study for the Following up of ConizationNo drug interventionsNot AvailableNot Availableunknown_status
NCT00925288
Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workersprevention4completed
NCT01158209
An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus Types in Women in EgyptNo drug interventionsNot AvailableNot Availablecompleted
NCT01824537
Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Studyprevention4active_not_recruiting
NCT01702337
Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) VaccineNo drug interventionsNot AvailableNot Availablecompleted
NCT00572832
Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University SettingpreventionNot Availablecompleted
NCT03032575
Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV InfectionNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00508170
Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT01384370
APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test ResultsNo drug interventionsNot AvailableNot Availablecompleted
NCT04411849
Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in AppalachiaNo drug interventionsscreeningNot Availablerecruiting
NCT06281119
Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Yearsprevention3not_yet_recruiting
NCT03302858
A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal WandNo drug interventionstreatment2unknown_status
NCT02464358
An Information-Motivation-Behavioral Skills (IMB) Intervention to Promote Human Papillomavirus Vaccination Among WomenNo drug interventionspreventionNot Availablecompleted
NCT06245486
Probiotc Lactobacillus Crispatus-M247 (Crispact®) Supplementation in the Sterilization of High-risk Human Papilloma (HPV-HR) VirusesNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT05309122
Cervical Cancer Screening StrategiesNo drug interventionsNot AvailableNot Availablerecruiting
NCT05860725
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine HesitancyNo drug interventionshealth_services_researchNot Availablerecruiting
NCT05587725
Human Papillomavirus in Young People Epidemiological Research 3No drug interventionsNot AvailableNot Availablerecruiting
NCT05662020
A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in Chinaprevention3active_not_recruiting
NCT01316120
Randomized Comparison of Vaginal Self Sampling for Human Papillomavirus (HPV) Testing by Standard Versus Dry Vaginal SwabsNo drug interventionsdiagnosticNot Availableunknown_status
NCT03158220
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)prevention3completed
NCT06577220
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women SupplementNo drug interventionsscreeningNot Availableenrolling_by_invitation
NCT03510091
Video-Assisted Counseling for HPV VaccinationNo drug interventionshealth_services_researchNot Availablecompleted
NCT02706691
BGJ398 in Treating Patients With FGFR Positive Recurrent Head and Neck Cancertreatment2terminated
NCT02355262
CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health CentersNo drug interventionsNot AvailableNot Availablecompleted
NCT00973362
Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® SystemNo drug interventionsscreening3completed
NCT00518180
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In AdolescentsNo drug interventionsprevention3completed
NCT03898167
Prospective Evaluation of Self-Testing to Increase ScreeningNo drug interventionsscreeningNot Availableenrolling_by_invitation
NCT04167501
Impact of HPV Vaccination on Cervical High Grade Lesions in FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT02188004
The Epidemiologic Study of Human Papillomavirus Infection and Related DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT05458869
Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual TraumaNo drug interventionsNot AvailableNot Availablecompleted
NCT05057312
Promoting HPV Vaccination Among Young Adults in TexasNo drug interventionspreventionNot Availablerecruiting
NCT04333212
HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine CervixNo drug interventionsdiagnosticNot Availablecompleted
NCT04587050
Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIVNo drug interventionsNot AvailableNot Availableunknown_status
NCT02827838
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancertreatment2completed
NCT01087164
Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health CentersNo drug interventionstreatmentNot Availableunknown_status
NCT04474821
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved AdultsNo drug interventionshealth_services_research4recruiting
NCT01532102
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital WartsNo drug interventionstreatment1 / 2completed
NCT00988884
A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)prevention3completed
NCT02816879
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With MenNo drug interventionsscreeningNot Availableactive_not_recruiting
NCT05907187
Research in Ethno-Medicine and Education (REMED)No drug interventionspreventionNot Availablecompleted
NCT05680454
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccineprevention1completed
NCT06213051
Comparison of Self-collection Using Dry Compared to Wet Swabs for HPV DetectionNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05237947
Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trialprevention4active_not_recruiting
NCT00520598
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)No drug interventionsprevention2completed
NCT01984697
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)No drug interventionsprevention3completed
NCT05774561
Role of Liquid Biopsies in HPV-associated Cancer Treatment MonitoringNo drug interventionsdiagnosticNot Availablerecruiting
NCT01082861
Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccinationprevention4terminated
NCT06199128
Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT03837028
The Human Papilloma Virus Effect on Sexual LifeNo drug interventionsNot AvailableNot Availablecompleted
NCT00823511
The Human Papillomavirus (HPV) Transmission Pilot StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT05981807
HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender PopulationNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00932009
Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian MenNo drug interventionsNot AvailableNot Availablecompleted
NCT03346915
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionNo drug interventionspreventionNot Availablecompleted
NCT01551537
Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri LankaNo drug interventionsNot AvailableNot Availablewithdrawn
NCT02460237
HPV Self-Test Intervention in Ohio AppalachiaNo drug interventionsscreeningNot Availablecompleted
NCT06207175
A Study to Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccineprevention3active_not_recruiting
NCT03345875
Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in BotswanaNo drug interventionsscreeningNot Availablecompleted
NCT01694875
Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® SystemNo drug interventionsNot AvailableNot Availablecompleted
NCT04226313
Self-sampling for Non-attenders to Cervical Cancer ScreeningNo drug interventionsscreeningNot Availablerecruiting
NCT02653118
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)Not AvailableNot Availableactive_not_recruiting
NCT06256718
Implementation of Evidence-Based Strategy (PC TEACH) for the Optimization of HPV Vaccination in Rural Primary CareNo drug interventionspreventionNot Availablerecruiting
NCT02382419
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy ParticipantsNo drug interventionsprevention2withdrawn
NCT05156541
Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Wartstreatment3completed
NCT04369339
Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal CytologyNo drug interventionsdiagnosticNot Availablecompleted
NCT03036930
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipientsprevention2active_not_recruiting
NCT05210348
Clinical Evaluation of Detection of High Risk HPV in UrineNo drug interventionsNot AvailableNot Availableunknown_status
NCT00892866
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical CellsNo drug interventionsotherNot Availableactive_not_recruiting
NCT05672966
Phase I Clinical Trial of a Candidate HPV VaccineNo drug interventionsprevention1not_yet_recruiting
NCT01078220
Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031)No drug interventionsNot AvailableNot Availablecompleted
NCT04660331
Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE StudyNo drug interventionshealth_services_researchNot Availablecompleted
NCT02897427
Throat and Other HPV-Related Cancers in Men: Identifying Them EarlyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03813576
Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot StudyNo drug interventionsdiagnosticNot Availableunknown_status
NCT03442062
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) VaccinationNo drug interventionshealth_services_researchNot Availablecompleted
NCT02785289
A Comparison of Cotton and Flocked Swabs for Vaginal Self CollectionNo drug interventionsscreeningNot Availablecompleted
NCT06005389
Serum Galectin-3 as a Marker of Human Papillomavirus InfectionNo drug interventionsNot AvailableNot Availablecompleted
NCT02354144
Lubricant Investigation in Men to Inhibit Transmission of HPV InfectionNo drug interventionsprevention2 / 3terminated
NCT01588301
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer PreventionNo drug interventionsscreening0completed
NCT05668572
A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV Vaccineprevention3active_not_recruiting
NCT01265212
Prevalence of Human Papillomavirus in Men Living in the Northern PlainsNo drug interventionsNot AvailableNot Availablecompleted
NCT01205412
An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of BahrainNo drug interventionsNot AvailableNot Availablecompleted
NCT04133610
HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal SwabsNo drug interventionsscreeningNot Availablecompleted
NCT05587738
Human Papillomavirus in Young People Epidemiological Research 4No drug interventionsNot AvailableNot Availablerecruiting
NCT03265743
HPV Vaccination in Women With Cystic FibrosisNo drug interventionsNot AvailableNot Availablecompleted
NCT00543543
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)prevention3completed
NCT01062074
GARDASIL Reexamination Study (V501-059)No drug interventionsNot AvailableNot Availablecompleted
NCT00481767
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.prevention3completed
NCT05334706
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)prevention2recruiting